Letter: improving detection of colorectal cancer using two-stage investigation process-faecal immunochemical test and urinary volatile organic compounds

Monika M Widlak^{1

2}, Matthew Neal³, Ramesh P Arasaradnam^{1

2

4

5}

Affiliations

¹ Department of Gastroenterology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
² Warwick Medical School, University of Warwick, Coventry, UK.
³ Department of Statistics, University of Warwick, Coventry, UK.
⁴ Faculty of Health and Life Sciences, University of Coventry, Coventry, UK.
⁵ Medical and Life Sciences, University of Leicester, Leicester, UK.

Comment

Monika M Widlak et al. Aliment Pharmacol Ther. 2019 Jun.

. 2019 Jun;49(11):1459-1460.

doi: 10.1111/apt.15278.

Monika M Widlak^{1

2}, Matthew Neal³, Ramesh P Arasaradnam^{1

2

4

5}

¹ Department of Gastroenterology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
² Warwick Medical School, University of Warwick, Coventry, UK.
³ Department of Statistics, University of Warwick, Coventry, UK.
⁴ Faculty of Health and Life Sciences, University of Coventry, Coventry, UK.
⁵ Medical and Life Sciences, University of Leicester, Leicester, UK.

No abstract available

Comment on

Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
Bond A, Greenwood R, Lewis S, Corfe B, Sarkar S, O'Toole P, Rooney P, Burkitt M, Hold G, Probert C. Bond A, et al. Aliment Pharmacol Ther. 2019 Apr;49(8):1005-1012. doi: 10.1111/apt.15140. Epub 2019 Mar 3. Aliment Pharmacol Ther. 2019. PMID: 30828825 Free PMC article.